Lesion Clinical Trials

227 recruitingLast updated: July 25, 2026

There are 227 actively recruiting lesion clinical trials across 51 countries. Studies span Not Applicable, Phase 2, Phase 3, Phase 1, Phase 4, Early Phase 1. Top locations include Houston, Texas, United States, New York, New York, United States, Boston, Massachusetts, United States. Updated daily from ClinicalTrials.gov.


Lesion Trials at a Glance

227 actively recruiting trials for lesion are listed on ClinicalTrialsFinder across 6 cities in 51 countries. The largest study group is Not Applicable with 113 trials, with the heaviest enrollment activity in Houston, New York, and Boston. Lead sponsors running lesion studies include M.D. Anderson Cancer Center, Peking University Third Hospital, and Aura Biosciences.

Treatments under study

About Lesion Clinical Trials

Looking for clinical trials for Lesion? There are currently 1 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Lesion trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Lesion clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 227 trials

Recruiting
Phase 2

A Study to Evaluate the Efficacy and Safety of Frexalimab, Brivekimig, or Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis or Minimal Change Disease

Focal Segmental GlomerulosclerosisGlomerulonephritis Minimal Lesion
Sanofi84 enrolled71 locationsNCT06500702
Recruiting

Top-Down Attentional Control of Visual-Processing

fMRIFocal Brain LesionFocal Lesions
National Institute of Mental Health (NIMH)300 enrolled1 locationNCT01087281
Recruiting
Not Applicable

"Expert IVUS-Eye" vs. IVUS-guided Left Main Bifurcation PCI

Coronary Artery Disease (CAD)Chronic Coronary SyndromeCoronary Bifurcation Lesion+1 more
Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health50 enrolled1 locationNCT07711106
Recruiting
Not Applicable

Clinical Outcomes Study of the Nexel Total Elbow

Degenerative ArthritisElbow Joint DestructionPost-traumatic Lesions+7 more
Zimmer Biomet134 enrolled11 locationsNCT02469662
Recruiting
Not Applicable

Biceps Tenodesis With 360 Suture Anchor Versus Self Locking Tenodesis In the Absence of Rotator Cuff Tears

SLAP Lesion
Clinique Générale dAnnecy98 enrolled1 locationNCT06772103
Recruiting

Crossover vs Accurate Ostial PCI for Medina 0.0.1 and 0.1.0 Left Main Bifurcation Lesions

Coronary Artery Disease (CAD)Coronary Bifurcation LesionLeft Main Coronary Artery Stenosis
Istanbul Mehmet Akif Ersoy Educational and Training Hospital1,000 enrolled2 locationsNCT07596706
Recruiting
Not Applicable

Oxygenation in Vascular Lesions of the Colon

Vascular Lesion
University of Chicago30 enrolled1 locationNCT06230731
Recruiting

The Effect of Lipedema on Knee Osteoarthritis

knee arthropathyKnee OsteoarthritisLipedema+5 more
Izmir Democracy University76 enrolled2 locationsNCT07575555
Recruiting
Not Applicable

BioPoly® Partial Resurfacing Knee Implant IDE

Knee OsteoarthritisKnee Pain ChronicCartilage Damage+3 more
BioPoly LLC152 enrolled4 locationsNCT06915363
Recruiting
Not Applicable

Nanochon Chondrograft First in Human (FIH) Early Feasibility Study (EFS) - Canada

Knee Cartilage Lesions
Nanochon, Inc.10 enrolled2 locationsNCT07249489
Recruiting

Galvanize Prospective/Retrospective Pulsed Electric Field Device Registry

Soft Tissue Lesion
Galvanize Therapeutics, Inc.1,000 enrolled11 locationsNCT05851430
Recruiting
Not Applicable

AGENT DCB STANCE: Safety and Effectiveness Study of AGENT Drug-Coated Balloon Compared to Standard of Care Percutaneous Coronary Intervention (PCI) Treatment for de Novo Coronary Lesions

Coronary Arterial Disease (CAD)de Novo Lesions in Native Coronary Arteries
Boston Scientific Corporation1,616 enrolled62 locationsNCT06959524
Recruiting
Phase 1Phase 2

Assessing Changes in Multi-parametric MRI in MS Patients Taking Clemastine Fumarate as a Myelin Repair Therapy

Multiple Sclerosis (MS)Multiple Sclerosis, Relapsing-RemittingMultiple Sclerosis, Primary Progressive+4 more
University of California, San Francisco74 enrolled1 locationNCT05359653
Recruiting
Not Applicable

Root Coverage Performance of Restorative Materials in Class V Cavities

Gingival RecessionNon-Carious Cervical Lesions (NCCLs)
Zeliha Başak Çakır Erdil30 enrolled1 locationNCT07687654
Recruiting
Phase 2Phase 3

A Phase 2/3 Study on the Efficacy and Safety of Mangaciclanol for Contrast-Enhanced MRI of CNS or Body in Adult Patients

Known or Highly Suspected Central Nervous System (CNS) LesionKnown or Highly Suspected Body (Excluding CNS) Lesion
GE Healthcare640 enrolled7 locationsNCT07472491
Recruiting
Not Applicable

Effect of Ozone Therapy on Remineralization of Initial Caries Lesions in Children

Dental CariesEarly Caries Lesion
Neslihan Atmaca80 enrolled1 locationNCT07671651
Recruiting
Not Applicable

Comparison of MI Paste Plus and Resin Infiltration in White Spot Lesions Following Orthodontic Treatment

White spot lesionsOrthodontic Appliance ComplicationCaries Arrested+1 more
University of Alberta62 enrolled1 locationNCT05733676
Recruiting
Not Applicable

Contribution of MUltiparametric Analysis in Bone Scintigraphy for the Characterisation of Solitary Bone Lesions

Bone Lesion
Central Hospital, Nancy, France68 enrolled1 locationNCT05934994
Recruiting

Application of Artificial Intelligence on the Diagnosis of Helicobacter Pylori Infection and Premalignant Gastric Lesion

Premalignant LesionHelicobacter Pylori Infection
National Taiwan University Hospital6,000 enrolled1 locationNCT05762991
Recruiting
Not Applicable

Artificial Intelligence-assisted Colonoscopy in the Detection and Characterization of Colorectal Lesions

Colorectal, CancerAdenomatous PolyposisColorectal Cancer (CRC)+1 more
Instituto do Cancer do Estado de São Paulo1,000 enrolled1 locationNCT07066046